Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gysler

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biology of Reproduction|January 17, 2014
Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonistsMai Hoang, Julie A Potter, Stefan M Gysler, et al.
Molecular Human Reproduction|April 1, 2016
Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8Stefan M Gysler, Melissa J Mulla, Marta Guerra, et al.
American Journal of Obstetrics and Gynecology|February 1, 1987
Prevalence of antibody to Chlamydia trachomatis in spontaneous abortion and infertilityP A Quinn, M Petric, M Barkin, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 30, 2014
Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblastStefan M Gysler, Melissa J Mulla, Meredith Stuhlman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative RegulatorsMelissa J Mulla, Ingrid C Weel, Julie A Potter, et al.
Human Pathology|March 9, 2018
MicroRNA signatures discriminate between uterine and ovarian serous carcinomasPei Hui, Stefan M Gysler, Mohamed Uduman, et al.
Gynecologic Oncology|July 23, 2025
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancerBradley R Corr, Ashley Haggerty, Stefan M Gysler, et al.
JCI Insight|January 25, 2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cellsHunter D Reavis, Stefan M Gysler, Grace B McKenney, et al.
Scientific Reports|January 27, 2023
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinomaSho Sato, Michael Gillette, Pamela R de Santiago, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biology of Reproduction|January 17, 2014
Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonistsMai Hoang, Julie A Potter, Stefan M Gysler, et al.
Molecular Human Reproduction|April 1, 2016
Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8Stefan M Gysler, Melissa J Mulla, Marta Guerra, et al.
American Journal of Obstetrics and Gynecology|February 1, 1987
Prevalence of antibody to Chlamydia trachomatis in spontaneous abortion and infertilityP A Quinn, M Petric, M Barkin, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 30, 2014
Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblastStefan M Gysler, Melissa J Mulla, Meredith Stuhlman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative RegulatorsMelissa J Mulla, Ingrid C Weel, Julie A Potter, et al.
Human Pathology|March 9, 2018
MicroRNA signatures discriminate between uterine and ovarian serous carcinomasPei Hui, Stefan M Gysler, Mohamed Uduman, et al.
Gynecologic Oncology|July 23, 2025
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancerBradley R Corr, Ashley Haggerty, Stefan M Gysler, et al.
JCI Insight|January 25, 2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cellsHunter D Reavis, Stefan M Gysler, Grace B McKenney, et al.
Scientific Reports|January 27, 2023
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinomaSho Sato, Michael Gillette, Pamela R de Santiago, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Pageof 3